Gastrin analogue administration adds no significant glycaemic benefit to a GLP-1 receptor agonist acutely or after washout of both analogues
Diabetes, Obesity and Metabolism | Apr 05, 2019
Efficacy of diacerein in reducing liver steatosis and fibrosis in patients with type 2 diabetes and non-alcoholic fatty liver disease: A randomized, placebo-controlled trial
Diabetes, Obesity and Metabolism | Apr 05, 2019
Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real-world clinical evidence
Diabetes, Obesity and Metabolism | Apr 05, 2019
Exenatide use and incidence of pancreatic and thyroid cancer: A retrospective cohort study
Diabetes, Obesity and Metabolism | Apr 05, 2019
Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin
Diabetes, Obesity and Metabolism | Apr 05, 2019
Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes
Diabetes, Obesity and Metabolism | Apr 05, 2019
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial
Diabetes, Obesity and Metabolism | Apr 05, 2019
Efficacy and safety of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase 3, open-label, 2:1 randomized, treat-to-target trial
Diabetes, Obesity and Metabolism | Apr 05, 2019
A variety of information related to Medicine and Health Care. It's all here.
